drugset / Trial / NCT01117636

Evaluate Analgesic Efficacy of Fast Release Aspirin

NCT01117636 ↗

Phase 3 Completed 514 enrolled Bayer
RandomizedCrossoverDouble-blindTreatment

Summary

The objective of the study is to evaluate the analgesic efficacy of a single, oral dose of fast release aspirin tablets, 1000 mg (2 x 500 mg) compared to regular aspirin tablets, 1000 mg (2 x 500 mg) and placebo in subjects with postsurgical dental pain.

Timeline

Start
2010-04-28
Primary completion
2010-07-07
Completion
2010-07-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 1000 mg Oral

Indications

No indication recorded.